[Evaluation of hearing in children with solid tumors treated by chemotherapy].
Ototoxicity of cisplatin is documented in during the last years. In material of 13 children with solid tumors (neuroblastoma, nephroblastoma, rhabdomyoscarcoma) treated with cisplatin, ototoxicity was observed in 2 cases. There were presented audiological findings. The role of otoacoustic emission measurements in monitoring of cisplatin--induced ototoxicity was underlined.
Gryczyńska
D
D
Klinika Otolaryngologii, Audiologii i Foniatrii Dzieciecej AM w Łodzi.
Rychwalska
M
M
Pekacka
K
K
Krawczyński
M
M
Bodalski
J
J
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001301:Audiometry, Pure-Tone; D001932:Brain Neoplasms / Q000188:drug therapy*; D002648:Child; D002945:Cisplatin / Q000009:adverse effects*; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced* / Q000175:diagnosis*; D006801:Humans; D008297:Male; D009447:Neuroblastoma / Q000188:drug therapy*; D017084:Otoacoustic Emissions, Spontaneous / Q000502:physiology
D000970:Antineoplastic Agents; D002945:Cisplatin